Although the detection of phosphorylated HER2 (pHER2) in metastatic PCa tumor biopsies supported previous clinical studies and was proposed as an adaptive mechanism to prolonged ADT exposure, it showed little clinical benefit in this context (32, 34–37). This evidence concerns the gene ERBB2 and neoplasm.